| ‘Minimal symptom expression’in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab J Vissing, S Jacob, KP Fujita, F O’Brien, JF Howard Journal of neurology 267 (7), 1991-2001, 2020 | 37 | 2020 |
| [</SUP> 11<//SUP> C] JNJ717 P2X7 receptor PET as a novel neuroinflammation target: ex vivo and in vivo comparison with [</SUP> 18<//SUP> F] DPA714 in human ALS D Van Weehaeghe, E Van Schoor, M Koole, J De Vocht, S Ceelen, ... Journal Of Cerebral Blood Flow And Metabolism 39, 120-121, 2019 | 2 | 2019 |
| 5Development of JC van den Bergen, BHA Wokke, P van Damme, AJ van der Kooi | | |
| A 62-year-old woman with muscle weakness L Dobbels, P Van Damme, M Mahler, X Bossuyt Clinical Chemistry 61 (9), 1133-1135, 2015 | 2 | 2015 |
| A cohesive E uropean policy for hepatitis B vaccination, are we there yet? T Lernout, G Hendrickx, A Vorsters, L Mosina, N Emiroglu, P Van Damme Clinical Microbiology and Infection 20, 19-24, 2014 | 37 | 2014 |
| A dose ranging study of hepatitis A vaccine in older, heavier healthy adults JS Bertino, S Thoelen, P van Damme, JP Bryan, PR Betcher The Journal of Infectious Diseases 178, 1998 | | 1998 |
| A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot-Marie-Tooth type 1A (vol 16, 433, 2021) S Attarian, P Young, TH Brannagan, D Adams, P Van Damme, ... Orphanet Journal Of Rare Diseases 19 (1), 2024 | | 2024 |
| A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A S Attarian, P Young, TH Brannagan, D Adams, P Van Damme, ... Orphanet journal of rare diseases 16, 1-12, 2021 | 39 | 2021 |
| A genome-wide association meta-analysis identifies a novel locus at 17q11. 2 associated with sporadic amyotrophic lateral sclerosis I Fogh, A Ratti, C Gellera, K Lin, C Tiloca, V Moskvina, L Corrado, ... Human molecular genetics 23 (8), 2220-2231, 2014 | 140 | 2014 |
| A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis HP Müller, MR Turner, J Grosskreutz, S Abrahams, P Bede, V Govind, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (6), 570-579, 2016 | 169 | 2016 |
| A mapping review of international guidance on the management and care of amyotrophic lateral sclerosis (ALS) AIWA Janssens, M Ruytings, A Al-Chalabi, A Chio, O Hardiman, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17 (5-6), 325-336, 2016 | 18 | 2016 |
| A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort K Moore, R Convery, M Bocchetta, M Neason, DM Cash, C Greaves, ... Applied Neuropsychology: Adult 29 (1), 112-119, 2022 | 28 | 2022 |
| A multi-center study of neurofilament assay reliability and inter-laboratory variability E Gray, P Oeckl, MDM Amador, U Andreasson, J An, K Blennow, ... Amyotrophic lateral sclerosis and frontotemporal degeneration 21 (5-6), 452-458, 2020 | 17 | 2020 |
| A Multicenter, Double-Blind, Placebo-Controlled, Pivotal Phase III Study (PLEO-CMT) of a Fixed Combination of Baclofen, Naltrexone and Sorbitol (PXT3003) for Charcot-Marie … S Attarian, P Young, T Sevilla, P van Damme, M Visser, F Thomas, ... European Journal Of Neurology 25, 372-372, 2018 | | 2018 |
| A multicentric approach to monocyte alterations in ALS SJ Brockmann, P Masrori, M Ribon, D Bhatia, D Brenner, ... ENCALS, Location: Edinburgh, 2023 | | 2023 |
| A phase 3 multicenter, prospective, open-label efficacy and safety study of immune globulin (human) 10% caprylate/chromatography purified in patients with myasthenia gravis … G Karelis, R Balasa, JL De Bleecker, T Stuchevskaya, A Villa, ... European neurology 81 (5-6), 223-230, 2019 | 26 | 2019 |
| A phase II− III trial of olesoxime in subjects with amyotrophic lateral sclerosis T Lenglet, L Lacomblez, JL Abitbol, A Ludolph, JS Mora, W Robberecht, ... European journal of neurology 21 (3), 529-536, 2014 | 141 | 2014 |
| A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis JM Shefner, ME Cudkowicz, O Hardiman, BM Cockroft, JH Lee, FI Malik, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20 (7-8), 584-594, 2019 | 49 | 2019 |
| A phase III trial of</i> tirasemtiv<//i> as a potential treatment for amyotrophic lateral sclerosis JM Shefner, ME Cudkowicz, O Hardiman, BM Cockroft, JH Lee, F Malik, ... Amyotrophic Lateral Sclerosis And Frontotemporal Degeneration 20 (7-8), 584-594, 2019 | | 2019 |
| A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis … FL Lombardo, S Spila Alegiani, F Mayer, M Cipriani, M Lo Giudice, ... Trials 24 (1), 792, 2023 | 2 | 2023 |
Ludo Van Den BoschKU Leuven & VIBVerified email at kuleuven.vib.be